Biotechnology

Alzheimer's disease, Biotechnology, Genetics, Longevity, Med Lifestyle, Medical News, Neurocognitive disorders, Neuroscience, World health
Blood test that identifies risk of Alzheimer’s disease shown to be highly accurate in large study

Researchers from Washington University School of Medicine in St. Louis have developed a highly reliable blood test for identifying Alzheimer’s disease, which uses the biomarkers amyloid beta proteins Aβ42 and

Biotechnology, Med Lifestyle, Medical News, Neurocognitive disorders, Neuroscience, World health
Stimulation of specialized ganglion restores full motor function in mice with Parkinson’s Disease

A research group from the University of Copenhagen have identified a specific area of neurons that when stimulated, restores full movement function in mice presenting Parkinson’s Disease. (Credit: A mouse

Biotechnology, COVID-19, COVID-19 news, Immunology, Med Lifestyle, Medical News, Pharmaceuticals, Vaccine studies, World health
Inhalation-based vaccinations shown to provide long-lasting protection against SARS-CoV-2

The inhalation-based vaccine showed to be equally as effective as currently used COVID-19 vaccinations, at fractions of the current dose. Researchers from McMaster University have demonstrated that an inhalation-based COVID-19

Biotechnology, Cancer, Cardiology, Genetics, Med Lifestyle, Medical News, Pharmaceuticals
New drug delivery system shown to effectively deliver therapeutic levels of gene-editing proteins

A Harvard research team has developed a new generation of virus-like particles, capable of delivering gene-editing proteins with high-specificity.

Biotechnology, Cardiology, Medical News
Sensors developed that can detect the electrical activity of a single cardiac cell

The first-of-its-kind nanotechnology is capable of measuring signals within individual cells, as well as between cells. The device even found that signals moving within individual cardiac cells move nearly five

Biotechnology, COVID-19, Medical News, Mood disorders, Neuroscience, Pharmaceuticals, World health
Antidepressant fluvoxamine shown to significantly reduce hospitalizations due to COVID-19

A new randomized-controlled trial has shown fluvoxamine, an antidepressant, significantly reduces hospitalizations due to COVID-19 (79 [11%] of 741 in the fluvoxamine group .vs. 119 [16%] of 756 in the